Biomedicine is worthy of affirmation, Lianyungang two parks selected in the 2020 Biopharmaceutical Industrial Park top 100 list

Pharmaceutical Network Industry Dynamics Recently, Sadie Consultants and Sina Pharmaceuticals jointly released the "Top 100 List of 2020 Biopharmaceutical Industrial Parks" to explore the development law of biopharmaceutical industrial parks, and enhance the overall competitiveness of China's biopharmaceutical industrial parkLianyungang Economic and Technological Development Zone and Lianyungang High-tech Zone ranked 4th and 21st, respectively, Lianyungang Economic and Technological Development Zone ranked among the national biopharmaceutical industry park to create a single national leaderLianyungang Economic and Technological Development Zone was approved by the Jiangsu provincial government in 1997 as a provincial high-tech zone, in February 2015 approved by the State Council upgraded to the national high-tech zone, the region adopted the "one area five parks" development model, "one area" is the core area, "five parks" is five industrial radiation parks, respectively, the new pharmaceutical industrial park, new materials industrial park, clean energy innovation industrial park, equipment manufacturing industry park and energy conservation and environmental protection science and technology parkat present, the pharmaceutical and health industry in the healthy nutrition food, innovative chemical drugs, innovative Chinese medicine and other fields to accumulate certain product technology advantagesfocus on the introduction of domestic and foreign innovative talent team, technology research and development resources, the construction of life and health engineering research and development center, the development of biomedicine, life science tools, advanced medical equipment, precision medicine, Internet medical and other new industries, new industriesLianyungang Economic Development Zone gathered a number of enterprises, including Hengrui Pharmaceuticals, Haussen Pharmaceuticals, Kangyuan Pharmaceuticals, has been among the main board, of which Hengrui Pharmaceuticals this year's market value reached 500 billion yuanand Kangyuan Pharmaceuticals, with a total investment of 600 million yuan, is stepping up construction of the project of intelligent solid preparation of Kangyuan Chinese medicinethe project will produce 5.5 billion capsules, 2.8 billion tablets and 700 tons of particulatesa number of other second-tier teams began to dabble in the listing process, the future is expected to be in the co-production board, small and medium-sized board listingLianyungang Development Zone Pharmaceutical Industry Base also aims to build a national biopharmaceutical industrial park, the preparation of the Lianyungang Economic and Technological Development Zone Biopharmaceutical Industry Plan (2018-2030) and the "Three-Year Action Plan", to clarify the direction of industrial development and optimize the industrial space layout, forming a "3 plus 2 x" industrial system"3" is to consolidate the development of chemical drugs, modern Chinese medicine and biological drugs three advantages of the industry, "2" is to cultivate the development of medicinal package materials and pharmaceutical accessories two supporting industries, "X" is to encourage the support of medical equipment, pharmaceutical equipment and other large health characteristics of the industry, accelerate the formation of a characteristic industrial development system structurestrengthen policies, finance, talent, platform, operation and other supporting support, to build an international pharmaceutical industry clusterthe Lianyungang High-tech Zone and Lianyungang Economic and Technological Development Zone are all on the list of the national biopharmaceutical industrial park, indicating that Lianyungang City's biopharmaceutical achievements have been affirmedis understood that, after more than 50 years of development, Lianyungang pharmaceutical plate has become the port city innovation effect and scale effect "win-win" industry, and laid Lianyunport in the industry's national positionin recent years, Lianyungang biopharmaceutical industry has developed rapidly, becoming a regional innovation talent gathering, strong innovation ability, significant innovation industry sector, forming a technology zone with Lianyungang Economic Development Zone as the core industrial development cluster, the construction of anti-tumor drugs, anti-hepatitis drugs, narcotic surgery drugs, new Chinese medicine, new pharmaceutical packaging materials and medical sterilization equipment and other six industries featuring the pharmaceutical health industry system, and gradually cultivate a number of leading enterprises in China biopharmaceutical industry has developed into Agang Gang with characteristics, vitality, competitive leading industry, in 2019, Lianyungang biopharmaceutical industry has created 22% of the city's industrial output value, contributing 38% of industrial tax revenue , according to the "13th Five-Year Plan" strategic emerging industry development plan of Lianyungang City, Lianyungang City plans to achieve the goal of doubling the strategic emerging industries by 2020, that is, the output value of more than 230 billion yuan, accounting for the proportion of industrial output value above the scale of 20% to 25%, of which the development of large health industry into a leading industry of 100 billion levels